The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOracle Power Regulatory News (ORCP)

Share Price Information for Oracle Power (ORCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.03
Bid: 0.028
Ask: 0.032
Change: -0.001 (-3.23%)
Spread: 0.004 (14.286%)
Open: 0.031
High: 0.031
Low: 0.03
Prev. Close: 0.031
ORCP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Placing & Exercise Of Warrants

28 Dec 2017 07:00

RNS Number : 3986A
Oracle Power PLC
28 December 2017
 

 28 December 2017

Oracle Power PLC

("Oracle" or "the Company")

 

 

Equity Placing at 2.3p per Ordinary Share

Exercise of Warrants

 

Oracle Power PLC (AIM:ORCP), the UK energy developer of a combined lignite coal mine and mine mouth power plant located in the south-eastern Sindh Province of Pakistan, announces that it has issued a total of 27,023,652 ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") at a price of 2.3 pence per share, representing an approximate premium of 20% to the closing mid-market price on 27 December 2017, pursuant to an equity fundraising. In addition, the Company also announces that Brandon Hill Capital Limited ("Brandon Hill"), the Company's broker, has exercised warrants held over 23,076,920 Ordinary Shares.

 

Equity placing and warrant exercise

The Company has raised £621,544 before costs by way of a placing of 27,023,652 new Ordinary Shares at a price of 2.3p per Ordinary Share to a new investor and the Company's joint broker, Brandon Hill, (the "Placing").

 

In addition, Brandon Hill has also exercised warrants held over 23,076,920 Ordinary Shares, at an exercise price of 0.65 pence per Ordinary Share (the "Exercise Price"), resulting in gross proceeds of £150,000 being receivable by the Company (the "Warrant Exercise"). The warrants were issued to Brandon Hill on 2 March 2015 at the Exercise Price, as remuneration for its role in a placing for the Company at that time. These warrants were due to expire in Q1 2018.

 

The proceeds of the Placing and the Warrant Exercise will provide Oracle with funds to repay the drawn principal and outstanding interest balance on the loan facility made available by Brandon Hill (announced on 25 September 2017) of £471,544, and will provide general working capital as the Company looks to move towards financial close on the basis of the Memorandum of Understanding with two major Chinese State Owned Enterprises, announced on 21 November 2017.

 

As part of the Placing, Brandon Hill has agreed to subscribe for 13,980,174 Ordinary Shares. Following the issue of the Ordinary Shares pursuant to the Placing and Warrant Exercise, Brandon Hill, together with its parent company, Optima Worldwide Group PLC, will hold 161,424,312 Ordinary Shares, representing 16.78 per cent of the enlarged issued share capital of the Company.

 

Related party transaction

Brandon Hill, in aggregate with its parent company, Optima Worldwide Group PLC, is a substantial shareholder of the Company. Accordingly, Brandon Hill's participation in the Placing constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. The directors of the Company consider, having consulted with the Company's nominated adviser, Grant Thornton UK LLP, that the terms of this transaction are fair and reasonable insofar as its shareholders are concerned.

 

 Shahrukh Khan, CEO of Oracle, said:

 "We are pleased to announce the equity placing at a healthy premium to the current market share price, which will allow us to repay the outstanding loan balance to Brandon Hill and will strengthen the Company's balance sheet as we move into 2018 and ahead of targeting financial close."

 

 

Settlement and dealings

Application will be made for the 50,100,572 Ordinary Shares, issued pursuant to the Warrant Exercise and Placing, which will rank pari passu with the Company's existing issued Ordinary Shares, to be admitted to trading on AIM. Dealings on AIM are expected to commence at 8:00am on or around 5 January 2018 ("Admission").

 

Following Admission, for the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), Oracle will have 961,883,698 Ordinary Shares in issue with voting rights attached (one vote per Ordinary Share). The Company does not hold any shares in treasury. This figure of 961,883,698 ordinary shares may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the DTRs.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information please contact:

 

Oracle Power PLC

Shahrukh Khan

 

+44 (0) 203 580 4314

Brandon Hill Capital Limited

Oliver Stansfield

 

+44 (0)203 463 5000

Peterhouse Corporate Finance

Charles Goodfellow

 

+44 (0) 207 220 9791

Grant Thornton UK LLP

Salmaan Khawaja, Richard Tonthat, Daniel Bush 

 

+44 (0) 207 383 5100

Blytheweigh

Tim Blythe, Camilla Horsfall, Megan Ray

 

+44 (0) 207 138 3204

Fortbridge Consulting

Matt Beale, Bill Kemmery

+44 (0)7966 389196

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFEFEFWFWSELE
Date   Source Headline
16th Dec 20224:57 pmRNSFormer Director Dealings
13th Dec 20225:00 pmRNSDirectorate change and director share purchases
29th Nov 20229:40 amRNSInvestor Presentation
28th Nov 20227:00 amRNSLand Lease for Green Hydrogen Project
17th Nov 20227:00 amRNSAppointment of new Public Relations Adviser
14th Nov 20227:00 amRNSLOI with TÜV SÜD on Green Hydrogen Certification
11th Nov 20227:00 amRNSInvestor Webinar
9th Nov 20227:00 amRNSDirector Share Purchases
1st Nov 20229:00 amRNSPrice Monitoring Extension
27th Oct 20227:00 amRNSQ3 Update & Shareholder Q&A Session
26th Oct 20227:00 amRNSMoU with Blue Carbon LLC
19th Oct 20227:00 amRNSthyssenkrupp Appointed for Green Hydrogen Project
11th Oct 20227:00 amRNSDirector Share Purchases
29th Sep 20227:00 amRNSDirectors Elect to Continue Share Purchase Plan
23rd Sep 20227:00 amRNSInterim Results
15th Sep 20227:00 amRNSLOI Issued: 1,200MW Power/Green Hydrogen Project
6th Sep 20227:00 amRNSCarbon Credit ITMO Alliance Strategy with KOTRA
1st Sep 20227:00 amRNSFormal Approval of Green Hydrogen Project LOI
30th Aug 20224:40 pmRNSSecond Price Monitoring Extn
30th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:36 amRNSFurther Advances to the Green Hydrogen Project JV
9th Aug 20227:00 amRNSDirector Share Purchases
5th Aug 20224:40 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
5th Aug 20229:05 amRNSSecond Price Monitoring Extn
5th Aug 20229:00 amRNSPrice Monitoring Extension
5th Aug 20227:00 amRNS£500,000 Placing to Support Green Hydrogen Project
3rd Aug 20227:00 amRNSLOI to be Issued for Green Hydrogen Project
21st Jul 20227:00 amRNSResult of AGM
11th Jul 202212:30 pmRNSQ2 Update and Shareholder Q&A Session
11th Jul 202211:04 amRNSFurther Advance to the Green Hydrogen Project JV
7th Jul 20227:00 amRNSDirector Share Purchases
27th Jun 20227:00 amRNSMoU with U.S. Hydrogen Fuel Cell Company
24th Jun 202210:24 amRNSReplacement: Audited Results for YE 31 Dec 2021
24th Jun 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
15th Jun 20227:00 amRNSHydrogen Storage & Hydrogen Refuelling MOU
14th Jun 20227:00 amRNSDirector Share Purchases
13th Jun 20227:00 amRNSNorthern Zone: Improved Gold Recovery up to 94.7%
9th Jun 20227:00 amRNSMetallurgical Results: Northern Zone Gold Project
6th May 20227:00 amRNSDirector Share Purchases
3rd May 20227:00 amRNSAppointment of Joint Broker
27th Apr 20223:30 pmRNSHolding(s) in Company
19th Apr 202210:04 amRNSHolding(s) in Company
19th Apr 202210:03 amRNSHolding(s) in Company
13th Apr 20227:00 amRNSQ1 Update and Shareholder Q&A Session
8th Apr 20227:00 amRNSHolding(s) in Company
6th Apr 20227:00 amRNSDirector Share Purchases
1st Apr 20227:00 amRNS£800,000 Raised to support Green Hydrogen Project
30th Mar 20227:00 amRNSJoint Venture to Advance Green Hydrogen Project
11th Mar 20227:00 amRNSUpdate on Green Hydrogen Production Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.